Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 9,105	$ 7,261
Prepaid expense and other current assets	33,885	13,674
Total current assets	42,990	20,935
Patents, net	96,153	94,100
Total assets	139,143	115,035
Current liabilities:
Accounts payable and accrued expenses	329,619	360,353
Accrued interest - related parties	1,039,182	951,442
Accrued expenses – related party	78,360	78,360
Derivative liabilities		4,217
Notes payable – related parties	3,339,293	2,847,958
Total current liabilities	4,786,454	4,242,330
Total liabilities	4,786,454	4,242,330
Stockholders' deficit
Preferred stock, $0.01 par value: Authorized shares – 10,000,000 Issued and outstanding shares – 3,262 at September 30, 2013 and December 31, 2012	33	33
Common stock, $0.01par value: Authorized shares - 100,000,000 Issued and outstanding shares – 73,291,008 at September 30, 2013 and 73,554,897 at December 31, 2012	732,910	735,549
Additional paid-in capital	31,968,516	31,966,377
Accumulated deficit	(37,348,770)	(36,829,254)
Total stockholders' deficit	(4,647,311)	(4,127,295)
Total liabilities and stockholders’ deficit	$ 139,143	$ 115,035